Abeona Therapeutics Inc. announced appointments of Dr. Vishwas (Vish) Seshadri, Ph.D., M.B.A., as Chief Executive Officer effective October 15, 2021. Until then, Dr. Seshadri will remain in his current role as Head of Research & Clinical Development and will lead the Company’s search for a new R&D leader with late-stage clinical and regulatory experience in preparation for two pivotal data readouts beginning in 2022.